4//SEC Filing
Anders Jack 4
Accession 0001610717-26-000012
CIK 0001628171other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:20 PM ET
Size
8.1 KB
Accession
0001610717-26-000012
Insider Transaction Report
Form 4
Anders Jack
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-07$42.45/sh+10,000$424,500→ 118,065 total - Sale
Common Stock
2026-01-07$98.00/sh−10,000$980,000→ 108,065 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-07−10,000→ 15,900 totalExercise: $42.45From: 2025-03-04Exp: 2031-03-03→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
- [F2]Includes 42,338 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001800668
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:20 PM ET
- Size
- 8.1 KB